R-25-29RESOLUTION NO. R-25-29
A RESOLUTION APPROVING THE CITY'S PARTICIPATION IN THE PROPOSED
SETTLEMENTS OF OPIOID-RELATED CLAIMS AGAINST ALVOGEN, AMNEAL,
APOTEX, HI.K.MA, INDIVIOR, MYLAN, SUN, AND ZYDUS, AND THEIR RELATED
CORPORATE ENTITIES, AND AUTHORIZING AND DIRECTING THE EXECUTION OF
ANY DOCUMENTS NECESSARY TO EFFECTUATE THE CITY'S PARTICIPATION IN
THE SETTLEMENTS
WHEREAS, the opioid epidemic that has cost thousands of human lives across the country also
impacts the City of Fairfax (the "City") by adversely impacting the delivery of emergency medical, law
enforcement, criminal justice, mental health and substance abuse services, and other City services; and
WHEREAS, the City has been required and will continue to be required to allocate substantial
taxpayer dollars, resources, staff energy and time to address the damage the opioid epidemic has caused
and continues to cause its citizens; and
WHEREAS, eight settlement proposals have been negotiated that will cause eight opioids
manufacturers, Alvogen, Inc., Amneal Pharmaceuticals, Inc., Apotex Corp, Hikma Pharmaceuticals
USA, Inc., Indivior Inc., Mylan Pharmaceuticals Inc, Sun Pharmaceutical Industries, Inc., and Zydus
Pharmaceuticals (USA) Inc. (collectively the "Manufacturers") to pay approximately $720 million
nationwide to resolve opioid-related claims against it; and
WHEREAS, the City has filed suit against certain of the manufacturers and their related
corporate entities for their role in the distribution, manufacture, and sale of the pharmaceutical opioid
products that have fueled the opioid epidemic that has harmed its citizens; and
WHEREAS, the City's suit seeks recovery of the public funds previously expended and to be
expended in the future to abate the consequences and harms of the opioid epidemic; and
WHEREAS, the City has previously approved and adopted the Virginia Opioid Abatement Fund
and Settlement Allocation Memorandum of Understanding (the "Virginia MOU"), and affirms that these
eight pending settlements shall be considered "Settlements" that are subject to the Virginia MOU, and
shall be administered and allocated in the same manner as the opioid settlements entered into previously
with the Distributors, Janssen, Teva, Allergan, Walmart, CVS, Walgreens, and Kroger; and
WHEREAS, the City's outside opioid litigation counsel has recommended that the City
participate in the eight settlements in order to recover its share of the funds that the Manufacturers
settlements would provide; and
WHEREAS, the City Attorney has reviewed the available information about this matter and
concurs with the recommendation of outside counsel.
NOW THEREFORE BE IT RESOLVED that the City Council hereby, on behalf of the City,
accepts the -Purdue Pharma bankruptcy plan and approves of the City's participation in the proposed
settlements of opioid-related claims against the Manufacturers and their related corporate entities, and
directs the City Attorney and/or the City's outside counsel, and the Mayor and/or the City Manager as
necessary, to execute the documents necessary to effectuate the City's participation in the settlements,
including the required release of claims against the Manufacturers.
Adopted this 9r' day of September, 2025.
Mayor
ATTEST:
City CrEv
Vote:
Mayor Read
Aye
Councilmember Amos
Aye
Councilmember Bates
Aye
Councilmember Hall
Aye
Councilmember Hardy -Chandler
Aye
Councilmember McQuillen
Aye
Councilmember Peterson
Aye